Boceprevir Improved Hepatitis C Response in Genotype 1 Patients-Dr. Paul Kwo Interview

Dr. Paul Kwo was on Your Health First with Dr. Joe Galati this past Sunday evening, discussing the latest results published this past week in the medical journal Lancet, which discussed the new finding with the drug Boceprevir. The response rates in chronic hepatitis C, genotype 1, are significantly improved compared to standard of care therapy currently available.

Listen to the interview here.

Paul Kwo HCV Interview

Tags: , , , ,

No comments yet.

Leave a Reply